All of our offerings

2022-01-16T21:14:34+00:00


Function (x), Inc.

Follow-On Offering
Common Stock
 

$5,000,000

Joint Book Runner
February 2017

2022-01-17T17:41:21+00:00


Medovex Corporation

PIPE Transaction
Common Stock & Warrants
 

$3,022,000

Exclusive Placement Agent
February 2017

2022-01-17T17:41:00+00:00

Towersteam Corporation

Confidentially Marketed
Public Offering
Common Stock

$4,000,000

Sole Book Runner
November 2016

2022-01-17T17:40:16+00:00

US Gold Corporation

Private Placement
Common Stock
 

$12,000,000

Exclusive Placement Agent
October 2016

2022-01-17T17:40:43+00:00


FTE Networks, Inc.

PIPE Transaction
Common Stock
& Warrants

$2,990,000

Exclusive Placement Agent
October 2016

2022-01-17T17:39:47+00:00


Spherix, Inc.

Confidentially Marketed
Public Offering
Common Stock

$2,500,000

Sole Book Runner
August 2016

2022-01-17T00:39:13+00:00


ImmunoCellular

Follow-On Offering
Common Stocks
& Warrants

$7,400,000

Lead Manager
August 2016

2022-01-17T01:05:30+00:00


Gemphire

Initial Public Offering
Common Stock
 

$30,000,000

Co-Manager
August 2016

2022-01-17T01:05:50+00:00


PhaseRx

Initial Public
Offering
Common Stock

$18,500,000

Book Runner
May 2016

2022-01-17T17:35:26+00:00

Medovex
Corporation

PIPE Transaction
Common Stock
& Warrants

$1,398,033

Placement Agent
April 2016

2022-01-17T00:45:30+00:00


Aspen University

PIPE
Common Stock
and Warrants

$6,000,000

Exclusive Placement Agent
April 2013

2022-01-17T00:46:00+00:00

Aeolus
Pharmaceuticals

PIPE Transaction
Common Stock
& Warrants

$6,750,000

Exclusive Placement Agent
December 2015

2022-01-17T17:33:29+00:00


Cerecor, Inc.

Initial Public Offering
Common Stock
& Warrants

$26,000,000

Lead Manager
October 2015

2022-01-17T17:33:11+00:00

Sevion
Therapeutics

PIPE Transaction
Common Stocks
& Warrants

$7,325,217

Exclusive Placement Agent
July 2015

2022-01-17T17:31:32+00:00

Viking
Therapeutics

Initial Public Offering
Common Stock
 

$27,600,000

Sole Book-Runner
May 2015

2022-01-17T17:30:45+00:00


ADMA Biologics

Follow-On Offering
Common Stock
 

$9,800,000

Co-Manager
March 2015

2022-01-17T17:30:17+00:00

Medovex
Corporation

Initial Public Offering
Common Stock
& Warrants

$9,200,000

Sole Book-Runner
December 2014

2022-01-17T17:28:18+00:00

Cel-Sci
Corporation

Follow-On Offering
Common Stock
& Warrants

$7,000,000

Sole Book-Runner
October 2014

2022-01-17T17:36:59+00:00


Spherix, Inc.

Registered
Direct Convertible
Preferred Stock

$19,990,000

Exclusive Placement Agent
June 2014

2022-01-17T17:27:20+00:00

Cel-Sci
Corporation

Follow-On Offering
Common Stock
& Warrants

$10,000,000

Joint Book-Runner
April 2014

2022-01-17T17:37:30+00:00


Spherix, Inc.

PIPE Transaction
Common Stock
& Warrants

$4,440,000

Exclusive Placement Agent
March 2014

2022-01-17T17:36:13+00:00


Inventergy, Inc.

Private Placement
Common Stock
 

$7,250,000

Exclusive Placement Agent
January 2014

2022-01-17T17:25:16+00:00

Cel-Sci
Corporation

Follow-On offering
Common Stock & Warrants
 

$3,000,000

Sole Book-runner
December 2013

2022-01-17T17:25:32+00:00


ADMA Biologics

Initial Public Offering
Common Stock
 

$28,347,500

Co-Manager
October 2013

2022-01-17T17:24:24+00:00

Cel-Sci
Corporation

Follow-On Offering
Common Stock
& Warrants

$17,826,087

Co-Manager
October 2013

2022-01-17T17:23:50+00:00

Relmada
Therapeutics

Convertible Bridge
Notes & Warrants
 

$750,000

Placement Agent
September 2013

2022-01-17T17:15:58+00:00


Alliqua

Common Stock &
Warrants
 

$3,000,000

Co-Manager
July 2013

2022-01-17T17:24:48+00:00

Relmada
Therapeutics

Convertible
Preferred Stock
& Warrants

$8,000,000

Placement Agent
September 2013

2022-01-17T17:15:48+00:00

BioSig
Technologies

Convertible
Preferred Stock
 

$2,800,000

Exclusive Placement Agent
July 2013